½ÃÀ庸°í¼­
»óǰÄÚµå
1661141

¼¼°èÀÇ ÇǺΠÇÊ·¯ ½ÃÀå º¸°í¼­ : Àç·áº°, ¼ºÁúº°, Áö¿ªº°(2025-2033³â)

Dermal Facial Fillers Market Report by Material Type (Temporary Fillers, Semi-Permanent Fillers, Permanent Fillers), Product Origin (Natural, Synthetic), and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 145 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÇǺΠÇÊ·¯ ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 37¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 67¾ï ´Þ·¯¿¡ µµ´ÞÇÏ¿© 2025-2033³â »çÀÌ 6.62%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

ÁøÇÇ ÇÊ·¯´Â ÇǺΠ¾Æ·¡¿¡ Á¸ÀçÇÏ´Â ¿¬ºÎÁ¶Á÷À» ä¿öÁÖ´Â ÁÖ»çÁ¦ÀÔ´Ï´Ù. ÁøÇÇ ÇÊ·¯¿¡´Â ÇÕ¼º ÇÊ·¯¿Í õ¿¬ ÇÊ·¯°¡ ÀÖ½À´Ï´Ù. ³ªÀ̰¡ µé¾î°¨¿¡ µû¶ó ¾ó±¼ÀÇ ¸ð¾çÀ» ¸¸µé°í, ÁöÁöÇϰí, º¼·ýÀ» ÁÖ´Â µ¥ µµ¿òÀÌ µÇ´Â õ¿¬ ¼öºÐ°ú ÇÔ²² ÇǺÎÀÇ À¯¿¬¼ºÀ» ÀÒ°Ô µË´Ï´Ù. ÀÌ Çö»óÀÌ ÁÖ¸§°ú óÁüÀÇ ¹ß»ýÀ¸·Î À̾îÁý´Ï´Ù. ÇǺΠÇÊ·¯´Â ¾ó±¼ÀÇ Æ¯Á¤ ºÎÀ§¿¡ ¹Ì¼¼ÇÑ ¾È¸é Áֻ縦 ÅëÇØ Àû¿ëÇÕ´Ï´Ù. À§ÀÇ ¿äÀÎÀ¸·Î ¼Õ½ÇµÈ Äݶó°ÕÀ» º¸ÃæÇÏ¿© ¾ó±¼ ÇǺθ¦ ºÎµå·´°Ô ²ø¾î¿Ã¸®°í ÆßÇÎÇÏ´Â ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÇǺΠÇÊ·¯´Â ³ëÈ­, ÁÖ¸§, óÁüÀ» °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ºñħ½ÀÀû Ä¡·áÀÇ ÇüÅ·Π»ç¿ëµÇ¸ç, ÁÖ¸§À» ÃÖ¼ÒÈ­Çϰųª Á¦°ÅÇϰųª, ÈäÅÍ·Î ÀÎÇÑ ÇÔ¸ôÀ» ²ø¾î¿Ã¸®°Å³ª, ÀÔ¼úÀ» °­È­Çϰųª, ¾ó±¼¿¡ Áֻ縦 ÅëÇØ ¼Õ½ÇµÈ ¿¬ºÎÁ¶Á÷À» º¸ÃæÇÏ¿© ¾ó±¼ ÇǺθ¦ Àþ¾îÁö°Ô ÇÕ´Ï´Ù.

ÇǺΠÇÊ·¯ ½ÃÀåÀº ¾ó±¼ÀÇ ÁÖ¸§°ú ÈäÅÍ Ä¡·á¸¦ ¿øÇÏ´Â »ç¶÷µé Áõ°¡·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡´Â ºÒ±ÕÇüÇÑ ½Ä½À°ü, ½ºÆ®·¹½º, ºÒ¸éÁõÀÇ Áö¼ÓÀûÀÎ Áõ°¡·Î ÀÎÇØ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¶Ç ´Ù¸¥ ÁÖ¿ä ÃËÁø¿äÀÎÀº ÀÌ Ä¡·á°¡ ºñħ½ÀÀûÀÌ¸ç ½ÃÇàÇÏ´Â µ¥ ¿À·£ ½Ã°£ÀÌ °É¸®Áö ¾Ê´Â´Ù´Â »ç½ÇÀÔ´Ï´Ù. ¶ÇÇÑ, ¼ö¼ú ÈÄ ¹ß»ýÇÏ´Â º¹ÀâÇÑ ¹®Á¦°¡ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ¼ö¼úÀÌ ¸Å¿ì ÀÛÀº Àý°³¸¦ ÇÊ¿ä·Î Çϱ⠶§¹®¿¡ ÈäÅͰ¡ ´«¿¡ ¶çÁö ¾Ê´Â´Ù´Â Á¡µµ Àüü ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ´Ù¸¥ ¿äÀÎÀ¸·Î´Â °í·ÉÈ­ Àα¸ Áõ°¡, °¡Ã³ºÐ ¼Òµæ Áõ°¡, À¯Æ©ºê³ª ÀνºÅ¸±×·¥°ú °°Àº ¼Ò¼È ¹Ìµð¾î Ç÷§ÆûÀ» ÅëÇÑ ÀÎÁöµµ Çâ»ó µîÀÌ ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • 2024³â ÇǺΠÇÊ·¯ ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â?
  • 2025-2033³â ¼¼°è ÇǺΠÇÊ·¯ ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ¼¼°è ÇǺΠÇÊ·¯ ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº?
  • Äڷγª19°¡ ¼¼°è ÇǺΠÇÊ·¯ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • ¼¼°è ÇǺΠÇÊ·¯ ½ÃÀåÀÇ Àç·á À¯Çüº° ½ÃÀå ºÐ¼®Àº?
  • ¼¼°è ÇǺΠÇÊ·¯ ½ÃÀåÀÇ Á¦Ç° ¿ø»êÁöº° ½ÃÀå ºÐ¼®Àº?
  • ¼¼°è ÇǺΠÇÊ·¯ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°è ÇǺΠÇÊ·¯ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ Á¢±Ù
    • Åé´Ù¿î Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ÇǺΠÇÊ·¯ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ºÐ¼® : Àç·áº°
  • ½ÃÀå ºÐ¼® : ¼ºÁúº°
  • ½ÃÀå ºÐ¼® : Áö¿ªº°
  • ½ÃÀå ¿¹Ãø
  • SWOT ºÐ¼®
    • °³¿ä
    • °­Á¡
    • ¾àÁ¡
    • ±âȸ
    • À§Çù
  • ¹ë·ùüÀÎ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
    • °³¿ä
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • °æÀï Á¤µµ
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù

Á¦6Àå ½ÃÀå ºÐ¼® : Àç·áº°

  • Àӽà ÇÊ·¯
    • Äݶó°Õ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • HA(È÷¾Ë·ç·Ð»ê)
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Äݶó°Õ ÀÚ±ØÁ¦
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • ¹Ý¿µ±¸ ÇÊ·¯
    • CaHA ÇÊ·¯
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • ¿µ±¸ ÇÊ·¯
    • Æú¸® ¸ÞŸũ¸±»ê ¸ÞÆ¿(PMMA)
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå ÇÏÀ̵å·Î Á©(PAAG)
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ºÐ¼® : ¼ºÁúº°

  • õ¿¬
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ÇÕ¼º
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ºÏ¹Ì
  • À¯·´
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«

Á¦9Àå ÇǺΠÇÊ·¯ Á¦Á¶ °øÁ¤

  • Á¦Ç° °³¿ä
  • ¿øÀç·á ¿ä°Ç
  • Á¦Á¶ °øÁ¤
  • ÁÖ¿ä ¼º°ø ¿äÀΰú ¸®½ºÅ© ¿äÀÎ

Á¦10Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Allergan Inc.
    • Galderma S.A.
    • Merz Pharma GmbH & Co. KGaA
    • AQTIS Medical BV(Sinclair Pharma Ltd.)
    • Bioha Laboratories
    • Cynosure Inc.
    • Cosmoderm Sdn Bhd(Vanity Cosmeceutical Sdn Bhd)
    • ColBar LifeScience Ltd.
    • Hangzhou Techderm Biological Products Co.
    • Regenerative Medical System
    • Suneva Medical Inc.
    • Sanofi S.A.
    • SciVision Biotech Inc.
    • Speciality European Pharma Limited(Contura International Ltd.)
    • Syneron Medical Ltd.(Candela Laser Corporation)
    • Ulthera Inc.
    • Visionmed Ltd.
LSH 25.03.19

The global dermal facial fillers market size reached USD 3.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.62% during 2025-2033.

A dermal facial filler is an injectable solution which fills the soft tissue present under the skin. Dermal fillers can be both synthetic and natural. With age, the flexibility of the skin is lost along with the natural hydration which helps in shaping, supporting and adding volume to the face. This phenomenon results in the occurrence of wrinkles and sagging of the skin. Dermal fillers are applied through tiny facial injections to specific areas of the face. They raise and pump the facial skin in a gentle manner by replacing the collagen lost due to the above factors. Dermal fillers are helpful in enhancing the appearance of aging, wrinkling and sagging skin. They are used in the form of a non-invasive treatment to rejuvenate facial skin by minimising or removing wrinkles, raising depressions caused by scars, augmenting lips, and replacing the lost soft-tissue through facial injections.

The dermal facial fillers market is strongly being driven by an increase in the number of people seeking treatment for facial wrinkles and scarring. This increase has occurred on account of a continuous rise in an imbalance diet, stress and insomnia. Another major driver of this market is the fact that this treatment is non-invasive and has does not take a long period of time to be conducted. Moreover, there has been a decrease in the number of complexities which occur post-surgery. In addition to this, the surgery does not have a prominent scarring as it requires very small incisions which has positively influenced the overall growth of the market. Other factors that are catalysing the growth of this market include a rising ageing population, increasing disposable incomes and raising awareness through social media platforms such as youtube and Instagram.

Key Market Segmentation:

Breakup by Material Type:

  • Temporary Fillers
  • Collagen
  • HA
  • Collagen Stimulators
  • Semi-Permanent Fillers
  • CaHa
  • Permanent Fillers
  • PMMA
  • PAAG

Based on the material type, the market has been segmented into temporary fillers, semi-permanent fillers and permanent fillers. Currently, temporary fillers dominate the market, holding the largest share.

Breakup by Product Origin:

  • Natural
  • Synthetic

Based on the product origin, the market has been segmented into natural and synthetic.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Competitive Landscape:

The competitive landscape of the market has also been examined with some of the key players being Allergan Inc., Galderma S.A., Merz Pharma GmbH & Co. KGaA, AQTIS Medical BV (Sinclair Pharma Ltd.), Bioha Laboratories, Cynosure Inc., Cosmoderm Sdn Bhd (Vanity Cosmeceutical Sdn Bhd), ColBar LifeScience Ltd., Hangzhou Techderm Biological Products Co., Regenerative Medical System, Suneva Medical Inc., Sanofi S.A., SciVision Biotech Inc., Speciality European Pharma Limited (Contura International Ltd.), Syneron Medical Ltd. (Candela Laser Corporation), Ulthera Inc., Visionmed Ltd.

This report provides a deep insight into the global dermal facial fillers market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the dermal facial fillers market in any manner.

Key Questions Answered in This Report

  • 1.What was the size of the global dermal facial fillers market in 2024?
  • 2.What is the expected growth rate of the global dermal facial fillers market during 2025-2033?
  • 3.What are the key factors driving the global dermal facial fillers market?
  • 4.What has been the impact of COVID-19 on the global dermal facial fillers market?
  • 5.What is the breakup of the global dermal facial fillers market based on the material type?
  • 6.What is the breakup of the global dermal facial fillers market based on the product origin?
  • 7.What are the key regions in the global dermal facial fillers market?
  • 8.Who are the key players/companies in the global dermal facial fillers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dermal Facial Fillers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Material Type
  • 5.5 Market Breakup by Product Origin
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Material Type

  • 6.1 Temporary Fillers
    • 6.1.1 Collagen
      • 6.1.1.1 Market Trends
      • 6.1.1.2 Market Forecast
    • 6.1.2 HA
      • 6.1.2.1 Market Trends
      • 6.1.2.2 Market Forecast
    • 6.1.3 Collagen Stimulators
      • 6.1.3.1 Market Trends
      • 6.1.3.2 Market Forecast
  • 6.2 Semi-Permanent Fillers
    • 6.2.1 CaHa
      • 6.2.1.1 Market Trends
      • 6.2.1.2 Market Forecast
  • 6.3 Permanent Fillers
    • 6.3.1 PMMA
      • 6.3.1.1 Market Trends
      • 6.3.1.2 Market Forecast
    • 6.3.2 PAAG
      • 6.3.2.1 Market Trends
      • 6.3.2.2 Market Forecast

7 Market Breakup by Product Origin

  • 7.1 Natural
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Synthetic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Dermal Facial Fillers Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Raw Material Requirements
  • 9.3 Manufacturing Process
  • 9.4 Key Success and Risk Factors

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Allergan Inc.
    • 10.3.2 Galderma S.A.
    • 10.3.3 Merz Pharma GmbH & Co. KGaA
    • 10.3.4 AQTIS Medical BV (Sinclair Pharma Ltd.)
    • 10.3.5 Bioha Laboratories
    • 10.3.6 Cynosure Inc.
    • 10.3.7 Cosmoderm Sdn Bhd (Vanity Cosmeceutical Sdn Bhd)
    • 10.3.8 ColBar LifeScience Ltd.
    • 10.3.9 Hangzhou Techderm Biological Products Co.
    • 10.3.10 Regenerative Medical System
    • 10.3.11 Suneva Medical Inc.
    • 10.3.12 Sanofi S.A.
    • 10.3.13 SciVision Biotech Inc.
    • 10.3.14 Speciality European Pharma Limited (Contura International Ltd.)
    • 10.3.15 Syneron Medical Ltd. (Candela Laser Corporation)
    • 10.3.16 Ulthera Inc.
    • 10.3.17 Visionmed Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦